A 25-year-old primigravida at 32 weeks asks about RSV prevention for her newborn. According to ACIP 2023, which is correct?...

Question

A 25-year-old primigravida at 32 weeks asks about RSV prevention for her newborn. According to ACIP 2023, which is correct?

Accepted Answer

Maternal RSV vaccination (32-36 weeks) or infant nirsevimab are recommended, but both are not routinely needed together

Answer

Infants should receive palivizumab universally

Answer

Maternal RSV vaccine is given in first trimester

Answer

RSV vaccine is contraindicated in pregnancy

Answer

Nirsevimab is only for preterm infants

us-abfm MCQ (SBA): RSV Prevention-Maternal/Infant